Related Experiment Video
Updated: Dec 21, 2025
04:55
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
1.2K
COVID19: potential cardiovascular issues in pediatric patients
Deborah Bertoncelli1, Marta Guidarini2, Anna Della Greca3
1Pediatric Cardiology Unit, Parma General and University Hospital. dbertoncelli@ao.pr.it.
Acta Bio-Medica : Atenei Parmensis
|May 19, 2020
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-COV 2) can cause severe cardiovascular complications in adults and children with congenital heart disease. Early recognition of myocardial injury is crucial in pediatric COVID-19 cases.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Cardiovascular Medicine
Background:
- The global spread of SARS-COV 2 has highlighted significant cardiovascular implications in adults.
- While pediatric cases appear less severe, infants and toddlers are at risk for critical illness.
- Cardiovascular involvement is a major concern in COVID-19, increasing morbidity and mortality.
Purpose of the Study:
- To summarize current understanding of COVID-19's cardiovascular effects in children.
- To highlight potential cardiovascular complications in pediatric patients, including those with congenital heart disease.
- To emphasize the importance of recognizing myocardial injury and cardiovascular issues in pediatric COVID-19.
Main Methods:
- Review of existing literature on COVID-19 in pediatric populations.
- Analysis of reported cardiovascular manifestations in children with SARS-COV 2 infection.
- Comparison of COVID-19 presentations with Kawasaki disease.
Main Results:
- Children represent a smaller proportion of SARS-COV 2 infections and generally experience less severe disease.
- Infants and toddlers may be at higher risk for critical illness.
- Potential for myocardial injury and cardiovascular complications exists, requiring careful monitoring.
- Overlap with Kawasaki disease, especially atypical forms, is a noted concern.
Conclusions:
- Cardiovascular complications of COVID-19 in children warrant further investigation.
- Congenital heart disease may increase risk in pediatric COVID-19 patients.
- Vigilance for myocardial injury and cardiovascular issues is essential to prevent misdiagnosis and ensure appropriate management.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
190
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
190
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
148
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
130
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
130
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
169
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
169
01:20Imaging Studies for Cardiovascular System III: X-Ray
414
The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
414
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
277
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277